EUVIMEDOpdag EUVIMED
Studienprotokoll

The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies

Jennifer Robblee iD, Xurong Rachel Zhao, Mia T Minen, Benjamin W Friedman, Miguel A Cortel-LeBlanc iD, Achelle Cortel-LeBlanc, Serena L Orr iD

Headache: The Journal of Head and Face Pain · 2024-07 · 64 (7) · 869-872

DOI: 10.1111/head.14744 ↗

At a glance

Studienprotokoll in Headache: The Journal of Head and Face Pain, published online on 2024-06-03. Written by Jennifer Robblee and 6 co-authors. Institution: Lewis Headache Clinic, Department of Neurology, Barrow Neurological Institute, Dignity Health, Phoenix, Arizona, USA. Major MEDLINE topics: Migraine Disorders, Emergency Service, Hospital. Cited 5 times so far (Crossref); 9 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objectives

The primary objective of this proposed guideline is to update the prior 2016 guideline on parenteral pharmacotherapies for the management of adults with a migraine attack in the emergency department (ED).

Methods

We will conduct an updated systematic review and meta‐analysis using the 2016 guideline methodology to provide clinical recommendations. The same search strategy will be used for studies up to 2023, with a new search strategy added to capture studies of nerve blocks and sphenopalatine blocks. Medline, Embase, Cochrane, clinicaltrials.gov , and the World Health Organization International Clinical Trial Registry Platform will be searched. Our inclusion criteria consist of studies involving adults with a diagnosis of migraine, utilizing medications administered intravenously, intramuscularly, or subcutaneously in a randomized controlled trial design. Two authors will perform the selection of studies based on title and abstract, followed by a full‐text review. A third author will intervene in cases of disagreements. Data will be recorded in a standardized worksheet and subjected to verification. The risk of bias will be assessed using the American Academy of Neurology tool. When applicable, a meta‐analysis will be conducted. The efficacy of medications will be evaluated, categorizing them as “highly likely,” “likely”, or “possibly effective” or “ineffective.” Subsequently, clinical recommendations will be developed, considering the risk associated with the medications, following the American Academy of Neurology recommendation development process.

Results

The goal of this updated guideline will be to provide guidance on which injectable medications, including interventional approaches (i.e., nerve blocks, sphenopalatine ganglion), should be considered effective acute treatment for adults with migraine who present to an ED.

Conclusions

The methods outlined in this protocol will be used in the design of a future systematic review and meta‐analysis‐informed guideline, which will then be assessed by and submitted for endorsement by the American Headache Society.

Subjects

MeSH terms (MEDLINE)

Migraine DisordersEmergency Service, HospitalHumansSystematic Reviews as TopicAdultSocieties, MedicalPractice Guidelines as TopicMeta-Analysis as Topic

Author keywords

acute migraineacute treatmentadultsemergency departmentparenteral pharmacotherapies

Authors and institutions

  • Lewis Headache Clinic, Department of Neurology, Barrow Neurological Institute, Dignity Health, Phoenix, Arizona, USA.
  • Alberta Health Services, Alberta's Children Hospital, Calgary, Alberta, Canada.
  • Department of Neurology, NYU Langone Health, New York, New York, USA.
  • Department Population Health, NYU Langone Health, New York, New York, USA.
  • Department of Emergency Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Department of Emergency Medicine, Queensway Carleton Hospital, Ottawa, Ontario, Canada.

ORCID profiles: Jennifer Robblee, Miguel A Cortel-LeBlanc, Serena L Orr

Cite

APA

Robblee, J., Zhao, X. R., Minen, M. T., Friedman, B. W., Cortel-LeBlanc, M. A., Cortel-LeBlanc, A., & Orr, S. L. (2024). The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. Headache: The Journal of Head and Face Pain, 64(7), 869-872. https://doi.org/10.1111/head.14744

Vancouver

Robblee J, Zhao XR, Minen MT, Friedman BW, Cortel-LeBlanc MA, Cortel-LeBlanc A, et al. The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. Headache: The Journal of Head and Face Pain. 2024;64(7):869-872. doi:10.1111/head.14744

BibTeX
@article{Robblee2024,
  author = {Robblee, Jennifer and Zhao, Xurong Rachel and Minen, Mia T and Friedman, Benjamin W and Cortel-LeBlanc, Miguel A and Cortel-LeBlanc, Achelle and Orr, Serena L},
  title = {The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2024},
  volume = {64},
  number = {7},
  pages = {869--872},
  doi = {10.1111/head.14744}
}
Start for free →